• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人骨髓间充质干细胞培养:在无血清定义培养基中的快速有效分离和扩增。

Human mesenchymal stem cell culture: rapid and efficient isolation and expansion in a defined serum-free medium.

机构信息

Pharmaceutical Production Research Facility, Schulich School of Engineering, University of Calgary, 2500 University Drive NW, Calgary, Alberta, Canada.

出版信息

J Tissue Eng Regen Med. 2012 May;6(5):391-403. doi: 10.1002/term.441. Epub 2011 Jul 11.

DOI:10.1002/term.441
PMID:21744510
Abstract

Human mesenchymal stem cells (hMSCs) are typically obtained for research or therapeutic applications by isolating and subculturing adherent cells from bone marrow on tissue-culture substrates using growth media. The purity and properties of the resulting populations can be affected greatly by the conditions under which they are cultured. Fetal bovine serum (FBS), although ill-defined, has been widely used as a critical requirement for conventional hMSC culture. However, a defined serum-free medium would greatly facilitate the development of robust, clinically acceptable bioprocesses for reproducibly generating quality-assured cells. The present study provides evidence demonstrating that a defined serum-free medium (PPRF-msc6) shows several beneficial features over a conventional FBS-containing medium for the production of hMSCs. When compared to control FBS-based cultures, PPRF-msc6 medium supported the derivation of hMSCs from primary cultures of bone marrow cells in a more rapid and consistent manner. Furthermore, hMSCs cultured in PPRF-msc6 exhibited: (a) a greater colony-forming capacity in primary as well as passaged cultures; (b) negligible lag phase and explicit exponential growth; (c) lower population doubling times (21-26 h vs 35-38 h between passage levels 1 and 10); (d) a greater number of population doublings (62 ± 4 vs 43 ± 2; over a 2 month period); and (e) a higher degree of homogeneity in size. Our data demonstrate that PPRF-msc6 is an important development which opens the door for the rapid, efficient and reproducible production of hMSCs in clinical settings.

摘要

人骨髓间充质干细胞(hMSCs)通常通过在组织培养基质上从骨髓中分离和传代贴壁细胞,并使用生长培养基来获得,用于研究或治疗应用。培养条件极大地影响所得细胞群体的纯度和特性。胎牛血清(FBS)虽然定义不明确,但已被广泛用作传统 hMSC 培养的关键要求。然而,无血清的定义培养基将极大地促进稳健、可临床接受的生物工艺的发展,以可重复地生成质量保证的细胞。本研究提供的证据表明,与传统含 FBS 的培养基相比,无血清定义培养基(PPRF-msc6)在 hMSC 的生产中具有几个有益的特性。与基于对照 FBS 的培养物相比,PPRF-msc6 培养基以更快速且更一致的方式支持从骨髓细胞的原代培养物中衍生出 hMSCs。此外,在 PPRF-msc6 中培养的 hMSCs表现出:(a)在原代和传代培养物中具有更大的集落形成能力;(b)可忽略的迟滞期和明确的指数生长;(c)更低的群体倍增时间(第 1 代和第 10 代之间的 21-26 小时与 35-38 小时);(d)更高的群体倍增次数(2 个月期间的 62 ± 4 与 43 ± 2 次);和(e)更大的大小均匀度。我们的数据表明,PPRF-msc6 是一个重要的发展,为在临床环境中快速、高效且可重复地生产 hMSCs 开辟了道路。

相似文献

1
Human mesenchymal stem cell culture: rapid and efficient isolation and expansion in a defined serum-free medium.人骨髓间充质干细胞培养:在无血清定义培养基中的快速有效分离和扩增。
J Tissue Eng Regen Med. 2012 May;6(5):391-403. doi: 10.1002/term.441. Epub 2011 Jul 11.
2
In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability.人骨髓间充质干细胞的体外扩增:血清的选择是细胞增殖、分化、基因表达及转录组稳定性的决定因素。
Stem Cells. 2005 Oct;23(9):1357-66. doi: 10.1634/stemcells.2005-0094. Epub 2005 Aug 4.
3
Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate.在添加自体人血小板裂解液的无动物血清培养基中扩增脂肪组织间充质干细胞。
Transfusion. 2009 Dec;49(12):2680-5. doi: 10.1111/j.1537-2995.2009.02346.x. Epub 2009 Aug 18.
4
Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.用于从骨髓中扩增间充质基质细胞的胎牛血清的人源替代物。
Stem Cells. 2009 Sep;27(9):2331-41. doi: 10.1002/stem.139.
5
Importance of serum source for the in vitro replicative senescence of human bone marrow derived mesenchymal stem cells.血清来源对人骨髓间充质干细胞体外复制性衰老的重要性。
J Cell Physiol. 2011 Nov;226(11):2908-15. doi: 10.1002/jcp.22637.
6
From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera?从骨髓到治疗应用:间充质干细胞在自体血清和胎牛血清中扩增过程中的不同行为及遗传/表观遗传稳定性?
Int J Dev Biol. 2008;52(8):1023-32. doi: 10.1387/ijdb.082725gt.
7
Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties.脐带组织来源的间充质干细胞在符合 GMP 标准的培养条件下生长最好,并保持其表型和功能特性。
J Immunol Methods. 2010 Dec 15;363(1):80-9. doi: 10.1016/j.jim.2010.10.008. Epub 2010 Oct 28.
8
Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine.在用于移植和再生医学的动物无血清培养基中加速并安全地扩增人间充质基质细胞。
J Cell Physiol. 2007 Oct;213(1):18-26. doi: 10.1002/jcp.21081.
9
Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media.不同培养液中培养的人骨髓间充质基质细胞的特性和生长情况。
Cytotherapy. 2009;11(7):874-85. doi: 10.3109/14653240903188947.
10
Rat marrow-derived mesenchymal stem cells developed in a medium supplemented with the autologous versus bovine serum.大鼠骨髓间充质干细胞在添加自体血清与牛血清的培养基中培养。
Cell Biol Int. 2009 May;33(5):607-16. doi: 10.1016/j.cellbi.2009.03.001. Epub 2009 Mar 13.

引用本文的文献

1
Extracellular Vesicles Generated by Mesenchymal Stem Cells in Stirred Suspension Bioreactors Promote Angiogenesis in Human-Brain-Derived Endothelial Cells.搅拌悬浮生物反应器中间充质干细胞分泌的细胞外囊泡促进人脑源性内皮细胞血管生成。
Int J Mol Sci. 2024 May 10;25(10):5219. doi: 10.3390/ijms25105219.
2
Physiological oxygen conditions enhance the angiogenic properties of extracellular vesicles from human mesenchymal stem cells.生理氧条件增强了人骨髓间充质干细胞来源的细胞外囊泡的血管生成特性。
Stem Cell Res Ther. 2023 Aug 23;14(1):218. doi: 10.1186/s13287-023-03439-9.
3
Expansion and characterization of human limbus-derived stromal/mesenchymal stem cells in xeno-free medium for therapeutic applications.
用于治疗应用的无动物源培养基中扩增和鉴定人角膜缘基质/间充质干细胞。
Stem Cell Res Ther. 2023 Apr 15;14(1):89. doi: 10.1186/s13287-023-03299-3.
4
Upscaling human mesenchymal stromal cell production in a novel vertical-wheel bioreactor enhances extracellular vesicle secretion and cargo profile.在新型垂直轮生物反应器中扩大人间充质基质细胞的生产规模可增强细胞外囊泡的分泌及货物谱。
Bioact Mater. 2022 Aug 2;25:732-747. doi: 10.1016/j.bioactmat.2022.07.004. eCollection 2023 Jul.
5
Genetic profiling of human bone marrow mesenchymal stromal cells after expansion in clinical grade human platelet lysate.在临床级人血小板裂解物中扩增后的人骨髓间充质基质细胞的基因谱分析。
Front Bioeng Biotechnol. 2022 Oct 12;10:1008271. doi: 10.3389/fbioe.2022.1008271. eCollection 2022.
6
Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia.间充质干细胞治疗在重症肢体缺血患者中的新作用。
Stem Cell Res Ther. 2022 Sep 6;13(1):462. doi: 10.1186/s13287-022-03148-9.
7
Production of Mesenchymal Progenitor Cell-Derived Extracellular Vesicles in Suspension Bioreactors for Use in Articular Cartilage Repair.悬浮生物反应器中骨髓间充质祖细胞衍生的细胞外囊泡的生产用于关节软骨修复。
Stem Cells Transl Med. 2022 Mar 3;11(1):73-87. doi: 10.1093/stcltm/szab008.
8
Expansion and characterization of bone marrow derived human mesenchymal stromal cells in serum-free conditions.在无血清条件下扩增和鉴定骨髓来源的人骨髓间充质基质细胞。
Sci Rep. 2021 Feb 9;11(1):3403. doi: 10.1038/s41598-021-83088-1.
9
Serum-Free Culture of Human Mesenchymal Stem Cell Aggregates in Suspension Bioreactors for Tissue Engineering Applications.用于组织工程应用的悬浮生物反应器中人间充质干细胞聚集体的无血清培养
Stem Cells Int. 2019 Nov 7;2019:4607461. doi: 10.1155/2019/4607461. eCollection 2019.
10
Mesenchymal Stem Cell Therapy for Ischemic Tissues.间充质干细胞疗法用于缺血组织
Stem Cells Int. 2018 Oct 8;2018:8179075. doi: 10.1155/2018/8179075. eCollection 2018.